These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3418329)

  • 1. High potency neuroleptics and violence in schizophrenics.
    Herrera JN; Sramek JJ; Costa JF; Roy S; Heh CW; Nguyen BN
    J Nerv Ment Dis; 1988 Sep; 176(9):558-61. PubMed ID: 3418329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A longitudinal therapeutic comparison between two prototypic neuroleptics (haloperidol and chlorpromazine) in matched groups of schizophrenics. Nontherapeutic interactions with trihexyphenidyl. Theoretical implications for potency differences.
    Singh MM; Kay SR
    Psychopharmacologia; 1975 Aug; 43(2):115-21. PubMed ID: 1103206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics.
    Singh MM; Kay SR
    Psychopharmacologia; 1975 Aug; 43(2):103-13. PubMed ID: 1103205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia.
    Small JG; Milstein V; Small IF; Miller MJ; Kellams JJ; Corsaro CJ
    Clin Electroencephalogr; 1987 Jul; 18(3):124-35. PubMed ID: 3652464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine.
    Kane J; Honigfeld G; Singer J; Meltzer H
    Arch Gen Psychiatry; 1988 Sep; 45(9):789-96. PubMed ID: 3046553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some methodological considerations for the clinical evaluation of neuroleptics--comparative effects of clozapine and haloperidol on schizophrenics.
    Itoh H; Miura S; Yagi G; Sakurai S; Ohtsuka N
    Folia Psychiatr Neurol Jpn; 1977; 31(1):17-24. PubMed ID: 863344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients.
    Krakowski MI; Czobor P; Nolan KA
    J Clin Psychopharmacol; 2008 Oct; 28(5):485-93. PubMed ID: 18794642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should chronic treatment-refractory akathisia be an indication for the use of clozapine in schizophrenic patients?
    Levin H; Chengappa KN; Kambhampati RK; Mahdavi N; Ganguli R
    J Clin Psychiatry; 1992 Jul; 53(7):248-51. PubMed ID: 1353492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Severe late dyskinesia caused by neuroleptics in a young female. Follow-up and treatment].
    Diedrich U; Müller P
    Nervenarzt; 1989 Dec; 60(12):759-61. PubMed ID: 2514384
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuroleptics. Violence as a manifestation of akathisia.
    Keckich WA
    JAMA; 1978 Nov; 240(20):2185. PubMed ID: 702732
    [No Abstract]   [Full Text] [Related]  

  • 11. [Schizophrenically disordered time perception and its modification by neuroleptics].
    Heim M; Morgner J
    Psychiatr Neurol Med Psychol (Leipz); 1985 Jul; 37(7):410-5. PubMed ID: 4048304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
    Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
    Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective response to neuroleptics in schizophrenia.
    Awad AG
    Schizophr Bull; 1993; 19(3):609-18. PubMed ID: 7901897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison.
    Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M
    Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precipitation of a psychoneuromotor syndrome by fluoxetine in a haloperidol-treated schizophrenic patient.
    D'Souza DC; Bennett A; Abi-Dargham A; Krystal JH
    J Clin Psychopharmacol; 1994 Oct; 14(5):361-3. PubMed ID: 7806697
    [No Abstract]   [Full Text] [Related]  

  • 16. The relationship of Akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidone.
    Seemüller F; Lewitzka U; Bauer M; Meyer S; Musil R; Schennach R; Riedel M; Doucette S; Möller HJ
    Pharmacopsychiatry; 2012 Nov; 45(7):292-6. PubMed ID: 22614116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Depressive syndromes within the scope of schizophrenic diseases].
    Heim M
    Psychiatr Neurol Med Psychol (Leipz); 1986 Dec; 38(12):716-21. PubMed ID: 3575544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clozapine in tardive Tourette syndrome.
    Jaffe E; Trémeau F; Sharif Z; Reider R
    Biol Psychiatry; 1995 Aug; 38(3):196-7. PubMed ID: 7578666
    [No Abstract]   [Full Text] [Related]  

  • 19. Clozapine induced akathisia: a case report and review of the evidence.
    Grover S; Sahoo S
    Indian J Pharmacol; 2015; 47(2):234-5. PubMed ID: 25878393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.